Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.

Journal of neuroimmunology - 18 Jan 2012

Toepfner Nicole, Cepok Sabine, Grummel Verena, Hemmer Bernhard

Abstract excerpt

Multiple Sclerosis (MS) is characterised by a chronic inflammation and demyelination of brain and spinal cord with a yet unknown aetiology. Based on multiple epidemiological and immunological studies, which suggest a role of Epstein-Barr virus (EBV) infection in the pathogenesis of MS, we investigated CD21 (CR2, complement receptor type 2), which serves as the EBV receptor. Serum concentrations of soluble CD21...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Interferon-beta
Share to Multiple Sclerosis, Chronic Progressive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis, Relapsing-Remitting

Share to Promoter Regions, Genetic

Share to Receptors, Complement 3d

Share to Sequence Analysis, DNA

Share to Young Adult

Source

Identifiers

PMID: 22137275
DOI: 10.1016/j.jneuroim.2011.11.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.PMID 22137275Read ↗

B cell activation leads to shedding of complement receptor type II (CR2/CD21)Semantic proximity Read ↗

A polymorphism within IL21R confers risk for systemic lupus erythematosus.Semantic proximity Read ↗

Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genesSemantic proximity Read ↗

Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-α: A Potential Role in Systemic Lupus ErythematosusSemantic proximity Read ↗

No evidence of IL21 association with multiple sclerosis in a Swedish population.Semantic proximity Read ↗

A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.Semantic proximity Read ↗

The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d bindingSemantic proximity Read ↗

CD21 and CD19 deficiency: Two defects in the same complex leading to different disease modalities.Semantic proximity Read ↗

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.Semantic proximity Read ↗

Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.Semantic proximity Read ↗

Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.Semantic proximity Read ↗

CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.